MedTrace Logo

Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2

NCT06467487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 214526

Last updated 2025-01-13

No results posted yet for this study

Summary

Based on the outcomes of the initial study (NCT05348603), this optimization study will employ the most effective interventions (letters and messages) and distribute these communications to underrepresented minorities to further promote interest in research. Optimized language will be distributed in English, Spanish, Portuguese, Chinese, Arabic, or Haitian Creole, based on preferred language identified in the patient profile in an electronic medical records system.

Conditions

  • Patient Participation

Interventions

OTHER

Traditional Letter

Patients receive a traditional letter.

OTHER

Direct to Patient Message

Patients receive a direct to patient message via the portal.

OTHER

Optimized Letter

Patients receive an optimized letter.

OTHER

Direct to Patient Message - Optimized

Patients receive an optimized direct to patient message via the portal.

Sponsors & Collaborators

  • Food and Drug Administration (FDA)

    collaborator FED

  • Yale University

    lead OTHER

Principal Investigators

  • Brian Smith, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-04
Primary Completion
2025-01-06
Completion
2025-01-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06467487 on ClinicalTrials.gov